Literature DB >> 27610643

Do More With Less: Tips and Techniques for Maximizing Small Biopsy and Cytology Specimens for Molecular and Ancillary Testing: The University of Colorado Experience.

Dara L Aisner, Mathew D Rumery, Daniel T Merrick, Kimi L Kondo, Hala Nijmeh, Derek J Linderman, Robert C Doebele, Natalie Thomas, Patrick C Chesnut, Marileila Varella-Garcia, Wilbur A Franklin, D Ross Camidge.   

Abstract

Context .- In an era in which testing of patient tumor material for molecular and other ancillary studies is of increasing clinical importance for selection of therapy, the ability to test on small samplings becomes critical. Often, small samplings are rapidly depleted in the diagnostic workup or are insufficient for multiple ancillary testing approaches. Objective .- To describe technical methodologies that can be implemented to preserve and maximize tissue for molecular and other ancillary testing. Data Sources .- Retrospective analysis of a case cohort from the University of Colorado, description of techniques used at the University of Colorado, and published literature. Conclusions .- Numerous techniques can be deployed to maximize molecular and other ancillary testing, even when specimens are from small samplings. A dedicated process for molecular prioritization has a high success rate, but also increases workload, which must be factored into establishing such a process. Additionally, establishing high-fidelity communication strings is critical for success of dedicated molecular prioritization of samples. Numerous approaches can be deployed for alternative specimen types, and several technical approaches can also aid in maximizing small specimens.

Entities:  

Year:  2016        PMID: 27610643      PMCID: PMC5509499          DOI: 10.5858/arpa.2016-0156-RA

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  20 in total

1.  Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions.

Authors:  Keith E Volmar; Michael O Idowu; Rhona J Souers; Raouf E Nakhleh
Journal:  Arch Pathol Lab Med       Date:  2015-09       Impact factor: 5.534

2.  Laser capture microdissection is a valuable tool in the preoperative molecular screening of follicular lesions of the thyroid: an institutional experience.

Authors:  M Bongiovanni; F Molinari; M Eszlinger; R Paschke; J Barizzi; E Merlo; L Giovanella; F Fasolini; F Cattaneo; F Ramelli; L Mazzucchelli; M Frattini
Journal:  Cytopathology       Date:  2014-12-08       Impact factor: 2.073

3.  Poor cell block adequacy rate for molecular testing improved with the addition of Diff-Quik-stained smears: Need for better cell block processing.

Authors:  Shuko Harada; Emmanuel Agosto-Arroyo; Jessica A Levesque; Evan Alston; Karen M Janowski; Gina M Coshatt; Isam A Eltoum
Journal:  Cancer Cytopathol       Date:  2015-05-08       Impact factor: 5.284

Review 4.  The State of Cell Blocks and Ancillary Testing: Past, Present, and Future.

Authors:  Anjali Saqi
Journal:  Arch Pathol Lab Med       Date:  2016-08-24       Impact factor: 5.534

Review 5.  The role of cytology specimens in molecular testing of solid tumors: techniques, limitations, and opportunities.

Authors:  Dara L Aisner; Sharon B Sams
Journal:  Diagn Cytopathol       Date:  2012-06       Impact factor: 1.582

Review 6.  Molecular diagnostic testing in breast cancer.

Authors:  Brygida Berse; Julie A Lynch
Journal:  Semin Oncol Nurs       Date:  2015-02-26       Impact factor: 2.315

7.  The use of stained cytologic direct smears for ALK gene rearrangement analysis of lung adenocarcinoma.

Authors:  Bryan L Betz; Catherine A Dixon; Helmut C Weigelin; Stewart M Knoepp; Michael H Roh
Journal:  Cancer Cytopathol       Date:  2013-03-27       Impact factor: 5.284

8.  Identification of Factors Affecting the Success of Next-Generation Sequencing Testing in Solid Tumors.

Authors:  Rashmi S Goswami; Rajyalakshmi Luthra; Rajesh R Singh; Keyur P Patel; Mark J Routbort; Kenneth D Aldape; Hui Yao; Hyvan D Dang; Bedia A Barkoh; Jawad Manekia; L Jeffrey Medeiros; Sinchita Roy-Chowdhuri; John Stewart; Russell R Broaddus; Hui Chen
Journal:  Am J Clin Pathol       Date:  2016-02-12       Impact factor: 2.493

9.  FNA smears as a potential source of DNA for targeted next-generation sequencing of lung adenocarcinomas.

Authors:  Amanda L Treece; Nathan D Montgomery; Nirali M Patel; Chris J Civalier; Leslie G Dodd; Margaret L Gulley; Jessica K Booker; Karen E Weck
Journal:  Cancer Cytopathol       Date:  2016-02-16       Impact factor: 5.284

Review 10.  The State of the Art in Colorectal Cancer Molecular Biomarker Testing.

Authors:  Raju K Pillai; Jean R Lopategui; Deepti Dhall; Maha Guindi; Thomas Slavin; Catherine E Lofton-Day; Scott D Patterson
Journal:  Adv Anat Pathol       Date:  2016-03       Impact factor: 3.875

View more
  11 in total

Review 1.  Anaplastic Lymphoma Kinase Testing: IHC vs. FISH vs. NGS.

Authors:  Xiaomin Niu; Jody C Chuang; Gerald J Berry; Heather A Wakelee
Journal:  Curr Treat Options Oncol       Date:  2017-11-16

2.  Evaluation of the EdgeSeq Precision Immuno-Oncology Panel for Gene Expression Profiling From Clinical Formalin-Fixed Paraffin-Embedded Tumor Specimens.

Authors:  Yang Shi; Xiaopeng Ma; Wei Shen; Tengfei Liu; Liang Liang; Silu Liu; Zhirong Shen; Yun Zhang; Pei Zhang
Journal:  Front Cell Dev Biol       Date:  2022-05-27

Review 3.  Molecular biomarker testing for non-small cell lung cancer: consensus statement of the Korean Cardiopulmonary Pathology Study Group.

Authors:  Sunhee Chang; Hyo Sup Shim; Tae Jung Kim; Yoon-La Choi; Wan Seop Kim; Dong Hoon Shin; Lucia Kim; Heae Surng Park; Geon Kook Lee; Chang Hun Lee
Journal:  J Pathol Transl Med       Date:  2021-05-11

4.  Pathologists at the Leading Edge of Optimizing the Tumor Tissue Journey for Diagnostic Accuracy and Molecular Testing.

Authors:  Luis E De Las Casas; David G Hicks
Journal:  Am J Clin Pathol       Date:  2021-05-18       Impact factor: 2.493

5.  Comparison of endoscopic ultrasound tissue acquisition methods for genomic analysis of pancreatic cancer.

Authors:  Sherif Elhanafi; Nadim Mahmud; Norge Vergara; Michael L Kochman; Koushik K Das; Gregory G Ginsberg; Michael Rajala; Vinay Chandrasekhara
Journal:  J Gastroenterol Hepatol       Date:  2018-12-10       Impact factor: 4.369

Review 6.  ALK in Non-Small Cell Lung Cancer (NSCLC) Pathobiology, Epidemiology, Detection from Tumor Tissue and Algorithm Diagnosis in a Daily Practice.

Authors:  Paul Hofman
Journal:  Cancers (Basel)       Date:  2017-08-12       Impact factor: 6.639

Review 7.  Advanced EUS Guided Tissue Acquisition Methods for Pancreatic Cancer.

Authors:  Pujan Kandel; Michael B Wallace
Journal:  Cancers (Basel)       Date:  2018-02-17       Impact factor: 6.639

Review 8.  Recent advancement in EUS-guided fine needle sampling.

Authors:  Pujan Kandel; Michael B Wallace
Journal:  J Gastroenterol       Date:  2019-02-26       Impact factor: 7.527

Review 9.  Practical Considerations Relating to Routine Clinical Biomarker Testing for Non-small Cell Lung Cancer: Focus on Testing for RET Fusions.

Authors:  Roy S Herbst; Dara L Aisner; Joshua R Sonett; Andrew T Turk; Joshua L Weintraub; Neal I Lindeman
Journal:  Front Med (Lausanne)       Date:  2021-01-21

Review 10.  Next generation sequencing in cytology.

Authors:  Pasquale Pisapia; Francesco Pepe; Roberta Sgariglia; Mariantonia Nacchio; Gianluca Russo; Floriana Conticelli; Ilaria Girolami; Albino Eccher; Claudio Bellevicine; Elena Vigliar; Umberto Malapelle; Giancarlo Troncone
Journal:  Cytopathology       Date:  2021-04-01       Impact factor: 2.073

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.